McKesson (NYSE:MCK) Downgraded by Wall Street Zen to Hold

McKesson (NYSE:MCK) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

MCK has been the topic of several other research reports. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Leerink Partners reiterated an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Barclays increased their target price on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a report on Wednesday, February 18th. Finally, JPMorgan Chase & Co. increased their target price on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $970.93.

McKesson Trading Down 0.8%

Shares of McKesson stock opened at $866.02 on Friday. The company has a market capitalization of $106.08 billion, a PE ratio of 24.91, a PEG ratio of 1.26 and a beta of 0.42. McKesson has a 12 month low of $637.00 and a 12 month high of $999.00. The stock’s fifty day simple moving average is $916.22 and its 200 day simple moving average is $850.46.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts predict that McKesson will post 32.77 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Maria Martinez sold 349 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director owned 301 shares in the company, valued at $282,900.87. This trade represents a 53.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. Insiders have sold 3,592 shares of company stock worth $3,518,555 over the last 90 days. 0.08% of the stock is currently owned by insiders.

Hedge Funds Weigh In On McKesson

Several hedge funds have recently modified their holdings of MCK. Brighton Jones LLC grew its holdings in shares of McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after acquiring an additional 798 shares in the last quarter. Caxton Associates LLP acquired a new stake in McKesson in the 1st quarter valued at about $233,000. Sivia Capital Partners LLC lifted its stake in McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares during the last quarter. Treasurer of the State of North Carolina lifted its stake in McKesson by 0.9% in the 2nd quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock valued at $42,958,000 after purchasing an additional 508 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in McKesson in the 2nd quarter valued at about $166,000. Institutional investors own 85.07% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.